We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Neogen Corp (NEOG) USD0.16

Sell:$16.94 Buy:$16.96 Change: $0.29 (1.66%)
Market closed |  Prices as at close on 23 February 2024 | Switch to live prices |
Change: $0.29 (1.66%)
Market closed |  Prices as at close on 23 February 2024 | Switch to live prices |
Change: $0.29 (1.66%)
Market closed |  Prices as at close on 23 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.

Contact details

620 Lesher Pl
United States
+1 (517) 3729200

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$3.72 billion
Shares in issue:
216.52 million
Health Care Supplies
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • John Adent
    President, Chief Executive Officer, Director
  • David Naemura
    Chief Financial Officer
  • Doug Jones
    Chief Operating Officer
  • Amy Rocklin
    Chief Legal & Compliance Officer
  • Steven Quinlan
    Vice President - Finance
  • James Walter
    Vice President - Global Operations
  • Jason Lilly
    Vice President, Americas, Australia and New Zealand

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.